Pay in 4 interest-free payments of $6.23 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
By preserving the potency and stability of peptide solutions, it facilitates long-term study and application for both researchers and wellness practitioners
Some patients may begin with weekly injections to establish steady nutrient levels, while others transition to biweekly or monthly treatments once those levels are stabilized
Got questions
Selective NNMT inhibitor substrate site-targeting mechanism with IC50 of 1.2 M in reference assay conditions Selectivity over related methyltransferases does not significantly affect other enzymes in the NAD salvage pathway at research concentrations Reduces intracellular 1-methylnicotinamide (1-MNA) formation in cell-based assay models Studied in adipocyte, liver, and skeletal muscle cell-based research models examining NNMT-dependent methylation pathway dynamics Referenced at Sigma-Aldrich (SML2832) and in peer-reviewed literature on NNMT enzyme biology Membrane-permeable quaternary quinolinium scaffold studied for intracellular NNMT target engagement in cell-based models Batch and lot identifiers on all labeling for full laboratory documentation compliance Research Background 5-Amino-1MQ was first characterized as a selective NNMT inhibitor in published research literature in 2018
CAS Number: 137525-51-0 PubChem CID: 9941957 ChemSpider ID: 8118261 Molecular Formula: C62H98N16O22 Molecular Weight: ~1419.53 g/mol This product is supplied as a high-quality, lyophilised powder in a sterile, sealed vial
Spray administration: Administer a measured amount of the TB-500 nasal spray by gently pressing the applicator, releasing the spray into the subject's nostril
